]>
IRCT2015040621626N1 IRCT 2017-04-21 Research and Technology Vice Chancellor, Arak University of Medical Sciences Effect of melatonin and vitamin E on working shift nurses’ sleep in ValiAsr Hospital located in Arak EEG Investigation Effect of melatonin, vitamin E administration on EEG and sleep quality in shift worker Nurses 2015-04-21 anticipated 90 Complete https://irct.ir/trial/18895 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 2-3 Sleep disorders. Intervention 1: Intervention of the first group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts. Intervention 2: Intervention of the second group: receiving a tablet of vitamin E/ 200 Units, orally every day for two months. Intervention 3: Intervention of the third group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts and a tablet of vitamin E/ 200 Units, orally every day for two months. Intervention 4: Control group: No intervention and measuring outcome variables.
public Dr. Mohsen Ebrahimi Monfared
Arak University of Medical Sciences, Alamolhoda st.
Arak Iran (Islamic Republic of) 3819693345 +98 86 3313 6055 info@arakmu.ac.ir Arak University of Medical Sciences scientific Dr. Mohsen Ebrahimi Monfared
Valiasr hospital, Arak
Arak Iran (Islamic Republic of) 863819693345 +98 86 3313 6055 info@arakmu.ac.ir Arak University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: to have at least one year of work experience؛ six night shifts per month؛ no second job؛ no history of sleep problems؛ no special underlying disease such as gland diseases and thyroid؛ no use of certain medications such as such as benzodiazepines and anticonvulsants, maximum age of 40 years. Exclusion criteria: Intolerance of melatonin or vitamin E؛recent history of melatonin or vitamin E for any other reason؛ a history of intolerance of melatonin or Vitamin E’s oral use؛ diagnosis of chronic systemic diseases (other than diabetes and hypertension)؛ and autoimmune disorders؛ infections؛ lack of regular drug use within two months of prescribed drugs؛ lack of consent to participate in the study؛ the nurses participated in the study who can’t be reachable for the intervention or follow-up were excluded. 22 years 40 years Female G47 Sleep disorders Treatment - Drugs Treatment - Drugs Treatment - Drugs N/A Intervention of the first group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts Intervention of the second group: receiving a tablet of vitamin E/ 200 Units, orally every day for two months Intervention of the third group: receiving a tablet of melatonin 3 mg orally every night for two months, except for working night shifts and a tablet of vitamin E/ 200 Units, orally every day for two months Control group: No intervention and measuring outcome variables Sleep quality. Timepoint: Befor intervention and 2 month after start of intervention. Method of measurement: TPR and weight.PSQI. EEG waves. Timepoint: Befor intervention and 2 month after start of intervention. Method of measurement: Electroencephalogram. Research and Technology Vice Chancellor, Arak University of Medical Sciences Approved 2015-02-23 Arak University of Medical Sciences Ethics committee Arak University of Medical Sciences, Almolhoda st. Arak Iran (Islamic Republic of)